ATYR geopolitical news & exposure
ATYR geopolitical news and exposure. ATYR appears in 231 Geopolitics Alpha notes. The newest is 12 Oct 2026, 21:20 UTC. Stored price-reaction rows cover 17 of those notes.
- Fruita woman shares breast cancer journey during Breast Cancer Awareness Month
12 Oct 2026, 21:20 UTC
- Nonmelanoma Skin Cancer Beyond Surgery: PDT, Immunotherapy, and Pipeline Agents
12 Oct 2026, 20:08 UTC
- Breast Cancer Awareness: Survivor shares what's next
12 Oct 2026, 16:43 UTC
- Fugitive businessman taken into US custody in Venezuela bribery case
12 Oct 2026, 13:14 UTC
- Goodwin Procter-Led Biotech Completes €30M Acquisition
12 Oct 2026, 12:06 UTC
- Southcoast Health shares about Breast Cancer Awareness Month
12 Oct 2026, 11:51 UTC
- Aicuris acquisition delivers new drug for Asahi Kasei
12 Oct 2026, 08:48 UTC
- Equity in earnings of RTW Biotech Opportunities Ltd USD – HAN:0BM
12 Oct 2026, 07:15 UTC
- Royalty Pharma EVP Marshall Urist sells $235,594 in shares
12 Oct 2026, 05:10 UTC
- Royalty Pharma EVP Marshall Urist sells $235,594 in shares By Investing.com
12 Oct 2026, 04:54 UTC
- Ohio woman shares her experience with early-onset breast cancer
11 Oct 2026, 21:00 UTC
- UA softball coach Courtney Deifel shares personal cancer-related story
11 Oct 2026, 18:05 UTC
- Charities and businesses wrestle with diesel cost
11 Oct 2026, 06:23 UTC
- 8-K - Moleculin Biotech, Inc. (0001659617) (Filer)
09 Oct 2026, 21:15 UTC
- 8-K - CTT PHARMACEUTICAL HOLDINGS, INC. (0001035422) (Filer)
09 Oct 2026, 20:13 UTC
- Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I
09 Oct 2026, 16:00 UTC
- Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I
09 Oct 2026, 16:00 UTC
- 8-K - GOLDENWELL BIOTECH, INC. (0001800373) (Filer)
09 Oct 2026, 13:50 UTC
- Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers; Guidance for Industry; Availability
09 Oct 2026, 12:45 UTC
- Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
09 Oct 2026, 12:45 UTC
- L Krenk DBA Maui Clinic Pharmacy; Decision and Order
08 Oct 2026, 12:45 UTC
- Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
08 Oct 2026, 12:45 UTC
- Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use
08 Oct 2026, 12:45 UTC
- Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams
08 Oct 2026, 12:45 UTC
- Vladimir Romaniv, P.A.; Decision and Order
08 Oct 2026, 12:45 UTC
- Challenges and Solutions in Lot-Level Food Traceability; Public Meeting
08 Oct 2026, 12:45 UTC
- Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications
08 Oct 2026, 12:45 UTC
- Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZANVASTRO (Zilganersen)
08 Oct 2026, 12:45 UTC
- Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction
08 Oct 2026, 12:45 UTC
- Alexandra R. Lovec, A.P.R.N.; Decision and Order
08 Oct 2026, 12:45 UTC
- Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
08 Oct 2026, 12:45 UTC
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements
08 Oct 2026, 12:45 UTC
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use
08 Oct 2026, 12:45 UTC
- Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC
08 Oct 2026, 12:45 UTC
- Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
08 Oct 2026, 12:45 UTC
- Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability
08 Oct 2026, 12:45 UTC
- Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
08 Oct 2026, 12:45 UTC
- Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
08 Oct 2026, 12:45 UTC
- Biotech and Pharma Industry News | BioPharma Dive
08 Oct 2026, 05:30 UTC
- 8-K - CTT PHARMACEUTICAL HOLDINGS, INC. (0001035422) (Filer)
07 Oct 2026, 21:30 UTC